P01-CA81534/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2000	2
2001	1
2002	1
2003	3
2004	7
2005	5
2006	3
2007	1
2008	4
2009	4
2010	10
2011	6
2012	14
2013	7
2014	8
2015	5
2016	1
2024	0

1

Emerging drug profile: cyclin-dependent kinase inhibitors.

Blachly JS, Byrd JC. Blachly JS, et al. Leuk Lymphoma. 2013 Oct;54(10):2133-43. doi: 10.3109/10428194.2013.783911. Epub 2013 Jul 29. Leuk Lymphoma. 2013. PMID: 23488658 Free PMC article. Review.

2

Targeting the apoptosis pathway in hematologic malignancies.

Zaman S, Wang R, Gandhi V. Zaman S, et al. Leuk Lymphoma. 2014 Sep;55(9):1980-92. doi: 10.3109/10428194.2013.855307. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24295132 Free PMC article. Review.

3

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Balakrishnan K, Gandhi V. Balakrishnan K, et al. Expert Opin Investig Drugs. 2012 Apr;21(4):409-23. doi: 10.1517/13543784.2012.668526. Epub 2012 Mar 9. Expert Opin Investig Drugs. 2012. PMID: 22409342 Free PMC article. Review.

4

Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemia.

Awan FT, Johnson AJ, Lapalombella R, Hu W, Lucas M, Fischer B, Byrd JC. Awan FT, et al. Leuk Lymphoma. 2010 Jan;51(1):27-38. doi: 10.3109/10428190903350405. Leuk Lymphoma. 2010. PMID: 20055657 Free PMC article. Review.

5

Immunogenetic therapy for B-cell malignancies.

Kipps TJ, Chu P, Wierda WG. Kipps TJ, et al. Semin Oncol. 2000 Dec;27(6 Suppl 12):104-9. Semin Oncol. 2000. PMID: 11225994 Review.

6

Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.

Rassenti LZ, Kipps TJ. Rassenti LZ, et al. Cytometry B Clin Cytom. 2006 Jul 15;70(4):209-13. doi: 10.1002/cyto.b.20129. Cytometry B Clin Cytom. 2006. PMID: 16906583 Free article. Review. No abstract available.

7

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia.

Jaglowski SM, Alinari L, Lapalombella R, Muthusamy N, Byrd JC. Jaglowski SM, et al. Blood. 2010 Nov 11;116(19):3705-14. doi: 10.1182/blood-2010-04-001230. Epub 2010 Jul 7. Blood. 2010. PMID: 20610811 Free PMC article. Review.

8

The B-cell receptor signaling pathway as a therapeutic target in CLL.

Woyach JA, Johnson AJ, Byrd JC. Woyach JA, et al. Blood. 2012 Aug 9;120(6):1175-84. doi: 10.1182/blood-2012-02-362624. Epub 2012 Jun 19. Blood. 2012. PMID: 22715122 Free PMC article. Review.

9

IRF4 mutations in chronic lymphocytic leukemia.

Havelange V, Pekarsky Y, Nakamura T, Palamarchuk A, Alder H, Rassenti L, Kipps T, Croce CM. Havelange V, et al. Blood. 2011 Sep 8;118(10):2827-9. doi: 10.1182/blood-2011-04-350579. Epub 2011 Jul 25. Blood. 2011. PMID: 21791429 Free PMC article.

10

Molecular pathways: targeting phosphoinositide 3-kinase p110-delta in chronic lymphocytic leukemia.

Herman SE, Johnson AJ. Herman SE, et al. Clin Cancer Res. 2012 Aug 1;18(15):4013-8. doi: 10.1158/1078-0432.CCR-11-1402. Epub 2012 Jun 18. Clin Cancer Res. 2012. PMID: 22711705 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year